Catecholamine Membrane Crosslinking for Biocompatibility

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for preparing catecholamine-based membranes are limited by the lack of a convenient and efficient synthesis method, resulting in fragile, non-robust, and toxic products that are not suitable for therapeutic or diagnostic applications.

Innovation Solution

A process involving the crosslinking of catechol derivatives with specific amines at mild pH conditions and agitation in the air/liquid interface, allowing for the formation of free-standing, self-supported membranes with controlled thickness and enhanced mechanical properties, adhesion, and biocompatibility.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Strength

If catecholamine coatings are prepared by dip-coating or copolymerization methods, then the coating adheres strongly to the substrate, but the coating cannot be detached without damage and the substrate rigidity limits its use

Engineering Contradiction:
Improveadhesion strengthVSAvoiddetachability and flexibility
Core Design Contradiction:
StrengthVSAdaptability or versatility

Solution Approach 1:

The invention extracts the catecholamine coating from the substrate by developing a detachment process using basic aqueous solutions. This allows the coating to be removed from the substrate without damage, solving the problem of irreversible adhesion while maintaining the coating's structural integrity during detachment

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention creates a dynamic system where the coating's adhesion properties can be changed on demand. The coating transitions from a strongly adhered state during formation to a detachable state when exposed to basic solutions, enabling both strong initial adhesion and subsequent flexibility/detachability

Inventive Principle:
Principle #15Dynamics

2Reliability

If electron beams are used for crosslinking to create self-supporting films, then chemical stability and sensitivity are improved, but severe conditions limit broad application

Engineering Contradiction:
Improvechemical stabilityVSAvoidsevere reaction conditions
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The invention replaces the mechanical/electronic crosslinking method (electron beams) with a chemical crosslinking method using catechol-amine chemistry. This substitution maintains chemical stability and film formation capability while eliminating the harmful effects of electron beam radiation and severe processing conditions

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The invention changes the reaction parameters from extreme conditions (electron beam radiation) to mild physiological conditions (aqueous solutions at neutral or slightly basic pH). This allows the same crosslinking function to be achieved under biocompatible conditions suitable for therapeutic and diagnostic applications

Inventive Principle:
Principle #35Parameter changes

3Object-affected harmful factors

If gas/liquid interface assembly is used to form polydopamine films, then reaction conditions are milder, but the film generates cracks and has poor stability

Engineering Contradiction:
Improvereaction condition severityVSAvoidfilm stability
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The invention creates a composite catecholamine film through crosslinking between catechol derivatives and amine-containing compounds. This composite structure enhances film stability and prevents crack formation while maintaining the mild reaction conditions of the gas/liquid interface assembly method

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The invention incorporates flexible spacers in the crosslinker molecules that provide curvature and flexibility to the film structure. This prevents rigid crack formation while maintaining film integrity under mild reaction conditions

Inventive Principle:
Principle #14Spheroidality (Curvature)

4Strength

If PEI is used as supporting material for dopamine-based membranes, then membrane hardiness is improved, but toxic by-products are generated under biological environment

Engineering Contradiction:
Improvemembrane hardinessVSAvoidtoxic by-products
Core Design Contradiction:
StrengthVSObject-generated harmful factors

Solution Approach 1:

The invention eliminates the harmful toxic by-products generated by PEI while maintaining membrane hardiness. By using biocompatible amine-containing crosslinkers instead of PEI, the harmful effect (toxicity) is removed while the beneficial effect (structural support and film stability) is preserved through the catechol-amine crosslinking mechanism

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The process yields robust, flexible, and biocompatible catecholamine-based membranes that support cell adhesion and proliferation, suitable for therapeutic and diagnostic applications without toxic by-products.

Implementation Method 1

When exposed to air, DOPA is prone to oxidation. The formed o-quinones may further react with a variety of nucleophiles in various pathways to form crosslinks.

Methodology Applied
Scientific EffectOxidation: Oxidation

Implementation Method 2

A well-known nucleophile is the amine that may react with o-quinones to form adducts either by Michael addition or Schiff base reaction.

Methodology Applied
Scientific EffectChemical Bonding: Chemical Bonding

Data Source

PatentUS20240277896A1Catecholamine-based membrane, process for its preparation and uses thereof
Publication Date: 2024.08.22 FUNDACIO INSTITUT CATALA DE NANOCIENCIA I NANOTECNOLOGIA (ICN2)
  • US20240277896A1 patent drawing
  • US20240277896A1 patent drawing
  • US20240277896A1 patent drawing

AI summary

The present invention provides a process for preparing a self-standing catecholamine-based membrane, the process comprising the steps of: (a) cross-linking a catechol derivative with an amine selected from the group consisting of: a known aliphatic amine hydrocarbon of formula (II); and an aromatic amine of formula (IIbis), in a liquid medium, wherein both the catechol and the amine are soluble, at a pH comprised from 6.5 to 10, and under appropriate agitation to create a catecholamine membrane in the air/liquid interface in the absence of any support; and b) isolating the membrane resulting from step (a) from the air/liquid interface. The resulting self-standing catecholamine-based membrane was robust, easy to handle and manipulate, highly flexible and adaptable to any kind of surface without breaking, and adhesive. In addition, the free-standing membrane of the invention shows a Janus character, with an unexpected nanopatterning in the water-contact side which endows the membranes of the invention with a higher roughness surface, something of value to promote cell adhesion.